USD 14.48
(-4.49%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | - USD | 0.0% |
2022 | - USD | -100.0% |
2021 | 5.82 Million USD | 0.0% |
2020 | - USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q3 | - USD | 0.0% |
2024 Q2 | - USD | 0.0% |
2024 Q1 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 FY | - USD | 0.0% |
2023 Q4 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2022 Q4 | - USD | -100.0% |
2022 Q2 | 7.87 Million USD | 5.13% |
2022 FY | - USD | -100.0% |
2022 Q3 | 750 Thousand USD | -90.47% |
2022 Q1 | 7.48 Million USD | 28.55% |
2021 Q3 | 4.28 Million USD | 59.09% |
2021 FY | 5.82 Million USD | 0.0% |
2021 Q4 | 5.82 Million USD | 36.04% |
2021 Q2 | 2.69 Million USD | 137.09% |
2021 Q1 | 1.13 Million USD | 0.0% |
2020 FY | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 Q4 | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Akoya Biosciences, Inc. | 17.87 Million USD | 100.0% |
AngioDynamics, Inc. | 60.61 Million USD | 100.0% |
AtriCure, Inc. | 67.89 Million USD | 100.0% |
Avinger, Inc. | 5.29 Million USD | 100.0% |
Azenta, Inc. | 128.19 Million USD | 100.0% |
BioLife Solutions, Inc. | 43.45 Million USD | 100.0% |
The Cooper Companies, Inc. | 735.6 Million USD | 100.0% |
Daxor Corporation | - USD | NaN% |
Ekso Bionics Holdings, Inc. | 5.05 Million USD | 100.0% |
Femasys Inc. | 667.11 Thousand USD | 100.0% |
GlucoTrack, Inc. | - USD | NaN% |
Harvard Bioscience, Inc. | 24.71 Million USD | 100.0% |
Hologic, Inc. | 679.8 Million USD | 100.0% |
ICU Medical, Inc. | 709.36 Million USD | 100.0% |
Intuitive Surgical, Inc. | 1.22 Billion USD | 100.0% |
KORU Medical Systems, Inc. | 3.48 Million USD | 100.0% |
LeMaitre Vascular, Inc. | 52.33 Million USD | 100.0% |
Innovative Eyewear, Inc. | 856.75 Thousand USD | 100.0% |
Innovative Eyewear, Inc. | 856.75 Thousand USD | 100.0% |
Masimo Corporation | 545 Million USD | 100.0% |
Microbot Medical Inc. | - USD | NaN% |
Meihua International Medical Technologies Co., Ltd. | 1.61 Million USD | 100.0% |
Merit Medical Systems, Inc. | 303.87 Million USD | 100.0% |
Nephros, Inc. | 2.47 Million USD | 100.0% |
NovoCure Limited | 38.15 Million USD | 100.0% |
NEXGEL, Inc. | 1.31 Million USD | 100.0% |
NEXGEL, Inc. | 1.31 Million USD | 100.0% |
Singular Genomics Systems, Inc. | 13.57 Million USD | 100.0% |
OraSure Technologies, Inc. | 47.61 Million USD | 100.0% |
Pro-Dex, Inc. | 15.26 Million USD | 100.0% |
Predictive Oncology Inc. | 494.37 Thousand USD | 100.0% |
Precision Optics Corporation, Inc. | 2.86 Million USD | 100.0% |
QuidelOrtho Corporation | 577.8 Million USD | 100.0% |
Repligen Corporation | 202.32 Million USD | 100.0% |
Sanara MedTech Inc. | 4.71 Million USD | 100.0% |
STAAR Surgical Company | 35.13 Million USD | 100.0% |
Sharps Technology, Inc. | 1.7 Million USD | 100.0% |
Utah Medical Products, Inc. | 9.58 Million USD | 100.0% |
DENTSPLY SIRONA Inc. | 624 Million USD | 100.0% |
Jin Medical International Ltd. | 5.05 Million USD | 100.0% |